10 studies on Ghrh receptor antagonist mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
**TNBC patients currently have no approved targeted therapy**, making every mechanistically distinct druggable axis clinically meaningful. The finding that `SV1` — not the canonical `GHRH-R` — dominates receptor expre…
**Tumors that express functional `p21/waf1` may be selectively vulnerable to GHRH antagonist therapy** — and conversely, cancers with silenced or mutated `p21` are likely non-responders. This mechanistic clarity could…
**GHRH antagonism via JMR-132 may represent a receptor-status-agnostic therapeutic axis in breast cancer**, addressing a major clinical gap: ER-negative tumors have few hormone-based treatment options. The dual activi…
**GHRH antagonists like JMR-132 may represent a mechanistically distinct antiproliferative strategy** for ovarian cancers expressing SV1 of the GHRH receptor, targeting the `EGFR-Akt` axis without being a direct EGFR …
**GHRH antagonists such as MZ-5-156 may have therapeutic utility not only as antiproliferatives but as suppressors of iNOS-driven nitrosative and oxidative stress in lung cancer**, a dual mechanism that broadens their…
The study demonstrates that antagonizing the GHRH receptor with compounds like MIA-690 is a potent strategy for inhibiting melanoma growth. This is achieved by forcing the tumor suppressor protein `p27` back into the …
These findings suggest a potential therapeutic role for GHRH antagonists in managing aggressive forms of papillary thyroid cancer, particularly those resistant to conventional treatments. The key implication is the se…
These findings establish `GHRH-R` as a significant molecular target and a prognostic biomarker in **human gastric cancer**. For clinicians and researchers, this opens a new therapeutic window, suggesting that GHRH-R a…
This in vitro research provides strong preclinical evidence for a new class of compounds in the fight against **prostate cancer**. The results suggest that GHRH-R antagonists like the `MIAMI` series could be a powerfu…
These findings suggest that GHRH receptor antagonism could be a novel and effective therapeutic strategy for mood disorders like anxiety and depression, and potentially for **PTSD**. For individuals exploring advanced…